1. Home
  2. OPK vs EVV Comparison

OPK vs EVV Comparison

Compare OPK & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • EVV
  • Stock Information
  • Founded
  • OPK 2007
  • EVV 2003
  • Country
  • OPK United States
  • EVV United States
  • Employees
  • OPK N/A
  • EVV N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • EVV Finance/Investors Services
  • Sector
  • OPK Health Care
  • EVV Finance
  • Exchange
  • OPK Nasdaq
  • EVV Nasdaq
  • Market Cap
  • OPK 1.0B
  • EVV 1.2B
  • IPO Year
  • OPK 1995
  • EVV N/A
  • Fundamental
  • Price
  • OPK $1.46
  • EVV $10.36
  • Analyst Decision
  • OPK Strong Buy
  • EVV
  • Analyst Count
  • OPK 3
  • EVV 0
  • Target Price
  • OPK $2.75
  • EVV N/A
  • AVG Volume (30 Days)
  • OPK 2.6M
  • EVV 323.7K
  • Earning Date
  • OPK 11-04-2024
  • EVV 01-01-0001
  • Dividend Yield
  • OPK N/A
  • EVV 9.66%
  • EPS Growth
  • OPK N/A
  • EVV N/A
  • EPS
  • OPK N/A
  • EVV N/A
  • Revenue
  • OPK $716,372,000.00
  • EVV N/A
  • Revenue This Year
  • OPK N/A
  • EVV N/A
  • Revenue Next Year
  • OPK $1.36
  • EVV N/A
  • P/E Ratio
  • OPK N/A
  • EVV N/A
  • Revenue Growth
  • OPK N/A
  • EVV N/A
  • 52 Week Low
  • OPK $0.85
  • EVV $8.52
  • 52 Week High
  • OPK $1.75
  • EVV $10.07
  • Technical
  • Relative Strength Index (RSI)
  • OPK 44.03
  • EVV 51.91
  • Support Level
  • OPK $1.44
  • EVV $10.28
  • Resistance Level
  • OPK $1.56
  • EVV $10.38
  • Average True Range (ATR)
  • OPK 0.06
  • EVV 0.09
  • MACD
  • OPK -0.00
  • EVV -0.02
  • Stochastic Oscillator
  • OPK 26.67
  • EVV 46.87

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.

Share on Social Networks: